- Home
- NKX vs RXST Comparison
NKX vs RXST Comparison
Compare NKX & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKX
- RXST
- Stock Information
- Founded
- NKX 2002
- RXST 1997
- Country
- NKX United States
- RXST United States
- Employees
- NKX N/A
- RXST N/A
- Industry
- NKX Finance/Investors Services
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NKX Finance
- RXST Health Care
- Exchange
- NKX Nasdaq
- RXST Nasdaq
- Market Cap
- NKX 562.3M
- RXST 553.1M
- IPO Year
- NKX N/A
- RXST 2021
- Fundamental
- Price
- NKX $11.75
- RXST $8.03
- Analyst Decision
- NKX
- RXST Hold
- Analyst Count
- NKX 0
- RXST 11
- Target Price
- NKX N/A
- RXST $19.40
- AVG Volume (30 Days)
- NKX 109.3K
- RXST 1.8M
- Earning Date
- NKX 01-01-0001
- RXST 08-07-2025
- Dividend Yield
- NKX 4.37%
- RXST N/A
- EPS Growth
- NKX N/A
- RXST N/A
- EPS
- NKX N/A
- RXST N/A
- Revenue
- NKX N/A
- RXST $148,310,000.00
- Revenue This Year
- NKX N/A
- RXST $17.41
- Revenue Next Year
- NKX N/A
- RXST $12.44
- P/E Ratio
- NKX N/A
- RXST N/A
- Revenue Growth
- NKX N/A
- RXST 46.70
- 52 Week Low
- NKX $9.78
- RXST $6.32
- 52 Week High
- NKX $12.00
- RXST $58.23
- Technical
- Relative Strength Index (RSI)
- NKX 52.18
- RXST 21.66
- Support Level
- NKX $11.72
- RXST $6.32
- Resistance Level
- NKX $11.81
- RXST $8.50
- Average True Range (ATR)
- NKX 0.08
- RXST 0.77
- MACD
- NKX 0.03
- RXST -0.52
- Stochastic Oscillator
- NKX 81.58
- RXST 21.50
About NKX Nuveen California AMT-Free Quality Municipal Income Fund
Nuveen California AMT-Free Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objectives are to provide current income exempt from regular federal and California income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.